PERSPECTA

News from every angle

← Back to headlines

Novo Nordisk Partners With OpenAI for AI Drug Discovery

Novo Nordisk, the maker of popular drugs like Wegovy and Ozempic, has announced a partnership with OpenAI. The collaboration aims to leverage artificial intelligence to accelerate drug discovery and development efforts.

14 Apr, 06:05 — 14 Apr, 10:28
PostShare

The Story

Analyzing sources…

Source Diversity

Source Diversity

High (67/100)
7 sources33/33
Spectrum spread— 3/5 buckets covered17/33
Far L
Left2
Left (2)
Rapplercnbc
Center1
Center (1)
bloomberg
Right4
Right (4)
wsjseeking-alphastar-malaysiachannel-news-asia
Far R
Geographic diversity— 4 regions17/34
US4Philippines1Malaysia1Singapore1

Sources

Showing 7 of 7 sources
bloombergHigh7h ago

Novo Taps OpenAI to Speed Development of New Obesity Drugs - Bloomberg.com

Novo Taps OpenAI to Speed Development of New Obesity Drugs  Bloomberg.com

Read full article →
wsjHigh3h ago

Wegovy Maker Novo Nordisk Strikes Deal With OpenAI to Speed Up Drug Discovery - WSJ

Wegovy Maker Novo Nordisk Strikes Deal With OpenAI to Speed Up Drug Discovery  WSJ

Read full article →
cnbcMostly Factual7h ago

Novo Nordisk partners with OpenAI as AI drug discovery hopes mount 

The partnership will enable Novo to better use AI to analyze complex datasets, and identify promising new drugs.

Read full article →
channel-news-asiaMostly Factual7h ago

Wegovy-maker Novo Nordisk partners with OpenAI to speed drug development

Read full article →
seeking-alphaMixed6h ago

Novo Nordisk teams up with OpenAI to boost AI-driven drug discovery efforts

Read full article →
RapplerMostly Factual5h ago

Ozempic-maker Novo Nordisk partners with OpenAI to speed up drug development

Novo Nordisk says pilot programs would begin across research and development, manufacturing, and commercial operations, with full integration planned by the end of 2026

By Reuters

Read full article →
star-malaysiaMixed7h ago

Wegovy-maker Novo Nordisk partners with OpenAI to speed drug development - The Star

Wegovy-maker Novo Nordisk partners with OpenAI to speed drug development  The Star

Read full article →

Coverage Timeline

First report: channel-news-asia · 14 Apr, 06:05Full coverage: 7 · 4hWindow: 4h
Left-leaningCenterRight-leaning
channel-news-asia14 Apr, 06:05First to report

Wegovy-maker Novo Nordisk partners with OpenAI to speed drug development

bloomberg14 Apr, 06:13

Novo Taps OpenAI to Speed Development of New Obesity Drugs - Bloomberg.com

star-malaysia14 Apr, 06:20

Wegovy-maker Novo Nordisk partners with OpenAI to speed drug development - The Star

cnbc14 Apr, 06:20

Novo Nordisk partners with OpenAI as AI drug discovery hopes mount 

seeking-alpha14 Apr, 06:37

Novo Nordisk teams up with OpenAI to boost AI-driven drug discovery efforts

1h later
Rappler14 Apr, 07:57

Ozempic-maker Novo Nordisk partners with OpenAI to speed up drug development

3h later
wsj14 Apr, 10:28Latest update

Wegovy Maker Novo Nordisk Strikes Deal With OpenAI to Speed Up Drug Discovery - WSJ

Related Stories

Amazon's First Sale Receipt Goes Viral, Drawing Reactions from Bezos and Musk

just now

Philippine Senate Considers Subpoena for Facebook Over Child Safety

just now

CICC reports 'loopholes' in Roblox age identification system

just now

Chinese Energy Storage Firms Sigenergy and Guoxia See Investor Excitement Amid AI Boom

7m ago